Table 1 Major baseline patient characteristics.
From: HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance
Clinical characteristics | Condition | SR | Non-SR | p | OR for SR (95% CI) | OR for non-SR (95% CI) |
|---|---|---|---|---|---|---|
Age (median = 50 years), n (%) | <50 years | 33 (47.8) | 36 (52.2) | 0.120 | 1.72 (0.86 to 3.43) | 1 |
≥50 years | 24 (34.8) | 45 (65.2) | 1 | 0.58 (0.29 to 1.16) | ||
Sex, n (%) | Male | 38 (36.9) | 65 (63.1) | 0.071 | 0.49 (0.22 to 1.08) | 1 |
Female | 19 (54.3) | 16 (45.7) | 1 | 2.03 (0.93 to 4.46) | ||
CD4+ (median = 551 cells/mL), n (%) | <551 cells/mL | 32 (46.4) | 37 (53.6) | 0.226 | 1.52 (0.77 to 3.03) | 1 |
≥551 cells/mL | 25 (36.2) | 44 (63.8) | 1 | 0.66 (0.77 to 3.03) | ||
HIV viral load, n (%) | Undetectable | 52 (41.6) | 73 (58.4) | 0.827 | 1.14 (0.35 to 4.02) | 1 |
Detectable | 5 (38.5) | 8 (61.5) | 1 | 0.88 (0.25 to 2.87) | ||
Use of ART, n (%) | Yes | 55 (40.4) | 81 (59.6) | 0.169 | 0 (0 to 2.42) | 1 |
No | 2 (100) | 0 | 1 | Infinity (0.41 to infinity) | ||
AIDS defining criteria in the past, n (%)a | Yes | 16 (45.7) | 19 (54.3) | 0.540 | 1.27 (0.58 to 2.77) | 1 |
No | 41 (39.8) | 62 (60.2) | 1 | 0.79 (0.36 to 1.73) |
